ACTIVE seeks motivated, diverse Arkansans with early-stage healthcare/health tech businesses, offering resources and networks to turn ideas into thriving startups.

Linking research minds to global markets

A nexus for innovation, entrepreneurial educational models, management of intellectual property, and industries.

Learn more

Licensing Opportunities

Explore the technologies we have available for licensing and commercialization

Discover Technology

Entrepreneurial Award

You can now make your contribution to the "Dr. Nancy M. Gray Entrepreneurial Award".

Contribution

Previous slide

Next slide

OPPORTUNITY

Accelerating Healthcare Entrepreneurship
in Arkansas

Empowering Arkansas entrepreneurs in healthcare and health tech. Receive comprehensive support and networking opportunities to accelerate your venture. Apply now to join the 2024 cohort and shape the future of healthcare entrepreneurship.

EVENT

Join the Maternal Health Hackathon
in Little Rock!

Make a difference by developing technology-driven solutions to enhance healthcare infrastructure, expand access to prenatal and postnatal care, and empower women with the tools they need for better health outcomes.

Recent technology:

Apparatus, system, and method of processing biopsy specimen

A biopsy pipette with a filter attached in an internal compartment of a pipette designed to prevent lodging and possible loss of the tissue specimen for analysis. A biopsy test tube may be provided with a biopsy bag attached in the internal compartment of the test tube. Further, a biopsy cassette may be provided with an opening configured to receive a pipette. An automated and non-automated system and method of using the biopsy pipette, biopsy test tube, and biopsy cassette in the processing of biopsy specimen is also disclosed.

September 19, 2022

Combretastatin analogs

The present invention relates novel heterocyclic analogs of combretastatin, their synthesis, and their use as anti-cancer compounds. In particular, compounds of Formula (I), Formula (II), and Formula (V) are provided.

September 12, 2022

Diagnosis, prognosis, identification, and classification of multiple myeloma based on gene expression profiling

Provided herein is a method for gene expression profiling multiple myeloma patients into distinct subgroups via DNA hybridization and hierarchical clustering analysis of the hybridization data where the results may further be used to identify therapeutic gene targets.

September 15, 2022

Our DNA

BioVentures was established as a formal outgrowth of the University of Arkansas for Medical Sciences‘ (UAMS) interest in promoting a biomedical technology industry for Arkansas and translating its research into products that benefit human health.

UAMS established BioVentures to maximize global, industrial interaction with the University of Arkansas faculty, as well as to facilitate technology transfer, the development of startup companies that are based on technology developed at UAMS, and contributions to Arkansas’ economic development.

BioVentures links the research minds at UAMS to global markets in order to advance Arkansas’ scientific and economic development.

News

AR Health Ventures Accelerator Announces Top Three Selected Projects

AR Health Ventures Accelerator proudly announces its inaugural cohort, funding innovative projects in biofilm inhibition, radiation-responsive cancer therapy, and advanced liver injury detection, marking a significant leap in medical research.

March 5, 2024